| Primary |
| Pain |
24.1% |
| Back Pain |
13.3% |
| Product Used For Unknown Indication |
12.0% |
| Breakthrough Pain |
7.2% |
| Depression |
7.2% |
| Substance Use |
4.8% |
| Blood Pressure |
3.6% |
| Anxiety |
2.4% |
| Back Disorder |
2.4% |
| Blood Testosterone Decreased |
2.4% |
| Bone Pain |
2.4% |
| Diabetes Mellitus |
2.4% |
| Drug Abuse |
2.4% |
| Joint Injury |
2.4% |
| Lyme Disease |
2.4% |
| Migraine |
2.4% |
| Nerve Injury |
2.4% |
| Abdominal Discomfort |
1.2% |
| Blood Cholesterol |
1.2% |
| Bursitis |
1.2% |
|
| Drug Ineffective |
37.2% |
| Vomiting |
9.3% |
| Drug Effect Delayed |
4.7% |
| Dyspnoea |
4.7% |
| Expired Drug Administered |
4.7% |
| Product Taste Abnormal |
4.7% |
| Troponin Increased |
4.7% |
| Abdominal Pain Upper |
2.3% |
| Acidosis |
2.3% |
| Cardiac Arrest |
2.3% |
| Chronic Obstructive Pulmonary Disease |
2.3% |
| Drug Screen Positive |
2.3% |
| Heart Rate Increased |
2.3% |
| Hyperhidrosis |
2.3% |
| Incorrect Route Of Drug Administration |
2.3% |
| Malaise |
2.3% |
| Nausea |
2.3% |
| No Adverse Event |
2.3% |
| Product Formulation Issue |
2.3% |
| Product Substitution Issue |
2.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
20.1% |
| Product Used For Unknown Indication |
17.6% |
| Pain |
10.1% |
| Back Pain |
6.9% |
| Depression |
6.9% |
| Hypertension |
6.9% |
| Blood Cholesterol Abnormal |
4.4% |
| Breakthrough Pain |
4.4% |
| Herpes Zoster |
3.8% |
| Insomnia |
3.1% |
| Arthritis |
1.9% |
| Blood Pressure |
1.9% |
| Hepatitis C |
1.9% |
| Hypogonadism |
1.9% |
| Rheumatoid Arthritis |
1.9% |
| Adnexa Uteri Pain |
1.3% |
| Anxiety |
1.3% |
| Back Disorder |
1.3% |
| Bone Pain |
1.3% |
| Bursitis |
1.3% |
|
| Drug Ineffective |
14.9% |
| Toxicity To Various Agents |
12.8% |
| Abdominal Pain Upper |
8.5% |
| Overdose |
8.5% |
| Unresponsive To Stimuli |
6.4% |
| Vomiting |
6.4% |
| Death |
4.3% |
| Disorientation |
4.3% |
| Drug Abuse |
4.3% |
| Malaise |
4.3% |
| Pain |
4.3% |
| Thinking Abnormal |
4.3% |
| Accidental Overdose |
2.1% |
| Accidental Poisoning |
2.1% |
| Acidosis |
2.1% |
| Atrial Fibrillation |
2.1% |
| Brain Injury |
2.1% |
| Cardiac Arrest |
2.1% |
| Chronic Obstructive Pulmonary Disease |
2.1% |
| Dyspnoea |
2.1% |
|
| Concomitant |
| Pain |
22.3% |
| Product Used For Unknown Indication |
16.1% |
| Drug Use For Unknown Indication |
11.4% |
| Anxiety |
4.7% |
| Smoking Cessation Therapy |
4.7% |
| Back Pain |
4.1% |
| Breakthrough Pain |
4.1% |
| Sleep Disorder |
3.6% |
| Back Disorder |
3.1% |
| Fibromyalgia |
3.1% |
| Nerve Injury |
3.1% |
| Neck Pain |
2.6% |
| Neuralgia |
2.6% |
| Vomiting |
2.6% |
| Contraception |
2.1% |
| Hepatitis C |
2.1% |
| Hypoaesthesia |
2.1% |
| Muscle Relaxant Therapy |
2.1% |
| Spinal Column Stenosis |
2.1% |
| Analgesic Therapy |
1.6% |
|
| Weight Increased |
12.8% |
| Vomiting |
7.7% |
| Abdominal Pain Upper |
5.1% |
| Anxiety |
5.1% |
| Blood Calcium Increased |
5.1% |
| Drug Ineffective |
5.1% |
| Medication Error |
5.1% |
| Nausea |
5.1% |
| Rectal Haemorrhage |
5.1% |
| Renal Failure |
5.1% |
| Somnambulism |
5.1% |
| Spinal Disorder |
5.1% |
| Spinal Operation |
5.1% |
| Weight Decreased |
5.1% |
| Withdrawal Syndrome |
5.1% |
| Aggression |
2.6% |
| Alanine Aminotransferase Increased |
2.6% |
| Coagulation Time Prolonged |
2.6% |
| Compartment Syndrome |
2.6% |
| Condition Aggravated |
2.6% |
|
| Interacting |
| Back Pain |
66.7% |
| Smoking Cessation Therapy |
33.3% |
|
|
